113 related articles for article (PubMed ID: 11041322)
1. NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats.
File SE
Psychopharmacology (Berl); 2000 Sep; 152(1):105-9. PubMed ID: 11041322
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.
File SE
Pharmacol Biochem Behav; 1997 Nov; 58(3):747-52. PubMed ID: 9329068
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils.
Gentsch C; Cutler M; Vassout A; Veenstra S; Brugger F
Behav Brain Res; 2002 Jul; 133(2):363-8. PubMed ID: 12110470
[TBL] [Abstract][Full Text] [Related]
4. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats.
Vassout A; Veenstra S; Hauser K; Ofner S; Brugger F; Schilling W; Gentsch C
Regul Pept; 2000 Dec; 96(1-2):7-16. PubMed ID: 11102646
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors.
Vendruscolo LF; Takahashi RN; Brüske GR; Ramos A
Psychopharmacology (Berl); 2003 Nov; 170(3):287-293. PubMed ID: 12915956
[TBL] [Abstract][Full Text] [Related]
6. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
[TBL] [Abstract][Full Text] [Related]
7. The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.
Cheeta S; Irvine EE; Kenny PJ; File SE
Psychopharmacology (Berl); 2001 Apr; 155(1):78-85. PubMed ID: 11374339
[TBL] [Abstract][Full Text] [Related]
8. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
9. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.
Cheeta S; Tucci S; Sandhu J; Williams AR; Rupniak NM; File SE
Brain Res; 2001 Oct; 915(2):170-5. PubMed ID: 11595206
[TBL] [Abstract][Full Text] [Related]
11. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats.
Papp M; Vassout A; Gentsch C
Behav Brain Res; 2000 Oct; 115(1):19-23. PubMed ID: 10996404
[TBL] [Abstract][Full Text] [Related]
12. The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway.
Niu XL; Hou JF; Li JX
Biol Res; 2018 May; 51(1):14. PubMed ID: 29843798
[TBL] [Abstract][Full Text] [Related]
13. Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction.
El-Hashim AZ; Wyss D; Lewis C
Pulm Pharmacol Ther; 2004; 17(1):11-8. PubMed ID: 14643166
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine withdrawal in the elevated plus-maze test in rats.
Chopin P; Assié MB; Briley M
Psychopharmacology (Berl); 1993; 110(1-2):19-26. PubMed ID: 7870883
[TBL] [Abstract][Full Text] [Related]
15. Quinolines and anxiety: anxiogenic effects of CGS 8216 and partial anxiolytic profile of PK 9084.
File SE; Lister RG
Pharmacol Biochem Behav; 1983 Feb; 18(2):185-8. PubMed ID: 6132404
[TBL] [Abstract][Full Text] [Related]
16. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine.
Irvine EE; Cheeta S; File SE
Behav Pharmacol; 1999 Nov; 10(6-7):691-7. PubMed ID: 10780511
[TBL] [Abstract][Full Text] [Related]
17. The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents.
Sánchez C; Arnt J; Costall B; Kelly ME; Meier E; Naylor RJ; Perregaard J
J Pharmacol Exp Ther; 1997 Dec; 283(3):1323-32. PubMed ID: 9400007
[TBL] [Abstract][Full Text] [Related]
18. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test.
Genn RF; Tucci S; Marco EM; Viveros MP; File SE
Pharmacol Biochem Behav; 2004 Mar; 77(3):567-73. PubMed ID: 15006468
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608).
Spooren WP; Schoeffter P; Gasparini F; Kuhn R; Gentsch C
Eur J Pharmacol; 2002 Jan; 435(2-3):161-70. PubMed ID: 11821022
[TBL] [Abstract][Full Text] [Related]
20. SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.
Wood MD; Reavill C; Trail B; Wilson A; Stean T; Kennett GA; Lightowler S; Blackburn TP; Thomas D; Gager TL; Riley G; Holland V; Bromidge SM; Forbes IT; Middlemiss DN
Neuropharmacology; 2001 Aug; 41(2):186-99. PubMed ID: 11489455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
